Literature DB >> 7256285

Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.

R L Tackett, J G Webb, P J Privitera.   

Abstract

Ventriculocisternal administration of dl- and d-propranolol produced dose-dependent increases in cerebrospinal fluid norepinephrine and reductions in blood pressure. A highly significant correlation was found between the increase in norepinephrine and the hypotensive effect. The propranolol-induced hypotension was prevented by intracisternal phentolamine. These data indicate that the hypotensive effect of centrally administered propranolol results from a drug-induced release of norepinephrine, which stimulates central alpha receptors to lower arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7256285     DOI: 10.1126/science.7256285

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Cold pressor stimulation diminishes P50 amplitude in normal subjects.

Authors:  Adam J Woods; John W Philbeck; Kenneth Chelette; Robert D Skinner; Edgar Garcia-Rill; Mark Mennemeier
Journal:  Acta Neurobiol Exp (Wars)       Date:  2011       Impact factor: 1.579

2.  Dopamine-beta-hydroxylase activity and ethanol-induced sleep time in selectively bred and heterogeneous stock mice.

Authors:  G P Horowitz; P S Dendel; A M Allan; L F Major
Journal:  Behav Genet       Date:  1982-11       Impact factor: 2.805

Review 3.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

4.  From facial mimicry to emotional empathy: a role for norepinephrine?

Authors:  Neil A Harrison; Robert Morgan; Hugo D Critchley
Journal:  Soc Neurosci       Date:  2010-05-17       Impact factor: 2.083

5.  S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.

Authors:  Richard Young; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

6.  Brief report: effects of propranolol in Tourette syndrome.

Authors:  J Sverd; S Cohen; J A Camp
Journal:  J Autism Dev Disord       Date:  1983-06

7.  The combined propranolol/TSST paradigm--a new method for psychoneuroendocrinology.

Authors:  Julie Andrews; Jens C Pruessner
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.